Skip to main content
. 2012 Mar 11;2012:392890. doi: 10.1155/2012/392890

Figure 5.

Figure 5

Effect of SP-Ang II and HO modulation on Urinary NGAL excretion was measured in the following groups; Vehicle- (Veh-) treated (n = 6), SP-AngII-treated (n = 6), chronic-SnPP- (Ch-SnPP-) treated (n = 6), SP-AngII/Ch-SnPP-treated (n = 6), late-SnPP-treated (n = 5), SP-AngII/late SnPP-treated (n = 5), chronic-CoPP- (Ch-CoPP-) treated (n = 6), SP-AngII/Ch-CoPP–treated (n = 6), late-CoPP-treated (n = 5), SP-AngII/Late-CoPP-treated (n = 6) rats. *P < 0.05 versus. control, # P < 0.05 versus. SP-AngII.